Jim Simons Novo Nordisk A S Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Renaissance Technologies LLC holds 4,936,796 shares of NVO stock, worth $277 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

4,936,796

Previous 6,821,396 27.63%

Holding current value

$277 Million

Previous $474 Million 28.07%

% of portfolio

0.48%

Previous 0.76%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$58.08 - $81.05 $109 Million - $153 Million	-1,884,600 Reduced 27.63%	4,936,796 $341 Million
Q1 2025 May 14, 2025	SELL	$69.3 - $90.95 $103 Million - $136 Million	-1,491,600 Reduced 17.94%	6,821,396 $474 Million
Q4 2024 Feb 13, 2025	BUY	$85.0 - $120.04 $10.5 Million - $14.8 Million	123,681 Added 1.51%	8,312,996 $715 Million
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $116 Million - $142 Million	-976,059 Reduced 10.65%	8,189,315 $975 Million
Q2 2024 Aug 09, 2024	SELL	$122.71 - $146.91 $199 Million - $238 Million	-1,620,700 Reduced 15.03%	9,165,374 $1.31 Billion
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $313 Million - $416 Million	-3,063,261 Reduced 22.12%	10,786,074 $1.38 Billion
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $209 Million - $251 Million	-2,380,141 Reduced 14.67%	13,849,335 $1.43 Billion
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $624 Million - $1.37 Billion	6,858,488 Added 73.19%	16,229,476 $1.48 Billion
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $223 Million - $247 Million	-1,431,300 Reduced 13.25%	9,370,988 $1.52 Billion
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $238 Million - $287 Million	-1,802,000 Reduced 14.3%	10,802,288 $1.72 Billion
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $277 Million - $366 Million	-2,704,583 Reduced 17.67%	12,604,288 $1.71 Billion
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $212 Million - $260 Million	-2,220,800 Reduced 12.67%	15,308,871 $1.53 Billion
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $88.2 Million - $104 Million	-854,300 Reduced 4.65%	17,529,671 $1.95 Billion
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $68.2 Million - $82.5 Million	-732,900 Reduced 3.83%	18,383,971 $2.04 Billion
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $242 Million - $295 Million	-2,523,800 Reduced 11.66%	19,116,871 $2.14 Billion
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $214 Million - $271 Million	-2,540,400 Reduced 10.51%	21,640,671 $2.08 Billion
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $45 Million - $56.4 Million	-665,600 Reduced 2.68%	24,181,071 $2.03 Billion
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $134 Million - $151 Million	-1,994,500 Reduced 7.43%	24,846,671 $1.68 Billion
Q4 2020 Feb 10, 2021	SELL	$63.89 - $73.8 $81.8 Million - $94.5 Million	-1,280,060 Reduced 4.55%	26,841,171 $1.87 Billion
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $37.5 Million - $41.3 Million	-588,600 Reduced 2.05%	28,121,231 $1.95 Billion
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $49.7 Million - $57.7 Million	849,605 Added 3.05%	28,709,831 $1.88 Billion
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $81.3 Million - $106 Million	1,643,200 Added 6.27%	27,860,226 $1.68 Billion
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $71.3 Million - $83.3 Million	1,430,310 Added 5.77%	26,217,026 $1.52 Billion
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $108 Million - $121 Million	2,264,800 Added 10.06%	24,786,716 $1.28 Billion
Q2 2019 Aug 12, 2019	BUY	$46.79 - $52.47 $55.1 Million - $61.8 Million	1,177,000 Added 5.51%	22,521,916 $1.15 Billion
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $27.8 Million - $31.6 Million	600,345 Added 2.89%	21,344,916 $1.12 Billion
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $862 Million - $980 Million	20,744,571 New	20,744,571 $956 Million

Others Institutions Holding NVO

# of Institutions

1,723

Shares Held

313M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $127B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account